US5639724A
(en)
*
|
1984-07-24 |
1997-06-17 |
Sandoz Ltd. |
Cyclosporin galenic forms
|
GB2222770B
(en)
*
|
1988-09-16 |
1992-07-29 |
Sandoz Ltd |
Pharmaceutical compositions containing cyclosporins
|
US6007840A
(en)
*
|
1988-09-16 |
1999-12-28 |
Novartis Ag |
Pharmaceutical compositions comprising cyclosporins
|
GR1000466B
(el)
*
|
1989-01-28 |
1992-07-30 |
Sandoz Ag |
Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης.
|
BE1003009A5
(fr)
*
|
1989-02-09 |
1991-10-22 |
Sandoz Sa |
Nouvelles compositions pharmaceutiques a base de cyclosporines.
|
US7081445B2
(en)
*
|
1989-02-20 |
2006-07-25 |
Novartis Ag |
Cyclosporin galenic forms
|
US4996193A
(en)
*
|
1989-03-03 |
1991-02-26 |
The Regents Of The University Of California |
Combined topical and systemic method of administration of cyclosporine
|
GB8916901D0
(en)
|
1989-07-24 |
1989-09-06 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
HU208491B
(en)
*
|
1990-11-27 |
1993-11-29 |
Gyogyszerkutato Intezet |
Process for producing oral pharmaceutical composition containing cyclosporin
|
IE921212A1
(en)
*
|
1991-04-19 |
1992-10-21 |
Affinity Biotech Inc |
Convertible microemulsion formulations
|
IL102236A0
(en)
*
|
1991-06-27 |
1993-01-14 |
Ltt Inst Co Ltd |
Topical preparations containing cyclosporin
|
US6262022B1
(en)
|
1992-06-25 |
2001-07-17 |
Novartis Ag |
Pharmaceutical compositions containing cyclosporin as the active agent
|
AU688920B2
(en)
*
|
1991-06-27 |
1998-03-19 |
Novartis Ag |
Transesterified corn oil products
|
GB9113872D0
(en)
*
|
1991-06-27 |
1991-08-14 |
Sandoz Ag |
Improvements in or relating to organic compounds
|
GB9208712D0
(en)
*
|
1992-04-22 |
1992-06-10 |
Sandoz Ltd |
Pharmaceutical compositions containing cyclosporin derivates
|
SG45449A1
(en)
*
|
1992-05-13 |
1998-01-16 |
Sandoz Ltd |
Ophthalmic compositions
|
DK0589843T3
(da)
*
|
1992-09-25 |
2002-04-02 |
Novartis Ag |
Cyclosporinholdige farmaceutiske præparater
|
WO1994023733A1
(de)
†
|
1993-04-20 |
1994-10-27 |
Dr. Rentschler Arzneimittel Gmbh & Co. |
Neue pharmazeutische zubereitungen zur oralen verabreichung enthaltend cyclosporin
|
NZ247516A
(en)
*
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
DE4447972B4
(de)
*
|
1993-05-27 |
2007-12-27 |
Novartis Ag |
Galenische Formulierungen
|
GB2278780B
(en)
*
|
1993-05-27 |
1998-10-14 |
Sandoz Ltd |
Macrolide formulations
|
AT408520B
(de)
*
|
1993-05-27 |
2001-12-27 |
Novartis Erfind Verwalt Gmbh |
Galenische formulierungen
|
CH686761A5
(de)
*
|
1993-05-27 |
1996-06-28 |
Sandoz Ag |
Galenische Formulierungen.
|
DE4322826A1
(de)
*
|
1993-07-08 |
1995-01-12 |
Galenik Labor Freiburg Gmbh |
Pharmazeutisches Präparat
|
GB2281697A
(en)
*
|
1993-09-14 |
1995-03-15 |
Euro Celtique Sa |
Laxative compositions in capsules
|
EP1033128B2
(en)
*
|
1993-09-28 |
2011-11-23 |
R.P. Scherer GmbH |
Soft gelatin capsule manufacture
|
GB2315216B
(en)
*
|
1993-10-05 |
1998-10-14 |
Ciba Geigy Ag |
Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
|
DE4340781C3
(de)
*
|
1993-11-30 |
2000-01-27 |
Novartis Ag |
Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
|
KR0146671B1
(ko)
*
|
1994-02-25 |
1998-08-17 |
김충환 |
사이클로스포린-함유 분말 조성물
|
GB9405304D0
(en)
*
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
US5447729A
(en)
*
|
1994-04-07 |
1995-09-05 |
Pharmavene, Inc. |
Multilamellar drug delivery systems
|
US5474979A
(en)
*
|
1994-05-17 |
1995-12-12 |
Allergan, Inc. |
Nonirritating emulsions for sensitive tissue
|
FI100692B
(fi)
*
|
1994-05-24 |
1998-02-13 |
Leiras Oy |
Menetelmä farmaseuttisten koostumusten valmistamiseksi, jolloin koostu mukset pohjautuvat mikroemulsiogeeleihin sekä uusia mikroemulsioihin p ohjautuvia geelejä
|
IL115742A
(en)
|
1994-10-26 |
2000-06-01 |
Novartis Ag |
Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
|
GB2308545B
(en)
*
|
1994-10-26 |
1999-06-02 |
Novartis Ag |
Pharmaceutical microemulsion preconcentrates
|
DE59510233D1
(de)
|
1994-11-03 |
2002-07-11 |
Novartis Ag |
Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
|
US5603951A
(en)
*
|
1994-11-09 |
1997-02-18 |
Hanmi Pharm. Ind. Co., Ltd. |
Cyclosporin-containing soft capsule compositions
|
HU215966B
(hu)
*
|
1994-11-21 |
1999-07-28 |
BIOGAL Gyógyszergyár Rt. |
Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
|
KR0167613B1
(ko)
*
|
1994-12-28 |
1999-01-15 |
한스 루돌프 하우스, 니콜 케르커 |
사이클로스포린-함유 연질캅셀제 조성물
|
JPH11505257A
(ja)
*
|
1995-05-19 |
1999-05-18 |
アボツト・ラボラトリーズ |
親油性薬物の自己乳化性製剤
|
US6696413B2
(en)
*
|
1995-06-16 |
2004-02-24 |
Hexal Ag |
Pharmaceutical preparation with cyclosporin A
|
EP0760237A1
(en)
*
|
1995-08-30 |
1997-03-05 |
Cipla Limited |
Oil-in-water microemulsions
|
DE19549852B4
(de)
|
1995-11-29 |
2009-06-04 |
Novartis Ag |
Cyclosporin enthaltende Präparate
|
NZ280689A
(en)
*
|
1995-12-15 |
1997-08-22 |
Bernard Charles Sherma Sherman |
Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
|
CZ288631B6
(cs)
*
|
1996-01-18 |
2001-08-15 |
Galena, A. S. |
Léčivé přípravky s obsahem cyklosporinu
|
GB9601120D0
(en)
|
1996-01-19 |
1996-03-20 |
Sandoz Ltd |
Organic compounds
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
US6245349B1
(en)
*
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
KR970064620A
(ko)
*
|
1996-03-05 |
1997-10-13 |
임성기 |
사이클로스포린-함유 외용약제 조성물
|
SE511313C2
(sv)
|
1997-01-13 |
1999-09-06 |
Gs Dev Ab |
Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
|
EP0988046B1
(en)
|
1997-01-30 |
2004-09-15 |
Novartis AG |
Oil-free pharmaceutical compositions containing cyclosporin a
|
US6426078B1
(en)
|
1997-03-17 |
2002-07-30 |
Roche Vitamins Inc. |
Oil in water microemulsion
|
AU728695B2
(en)
*
|
1997-07-29 |
2001-01-18 |
Boehringer Ingelheim International Gmbh |
Self-emulsifying formulation for lipophilic compounds
|
CA2294033C
(en)
|
1997-07-29 |
2007-01-09 |
Pharmacia & Upjohn Company |
Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
US6346511B1
(en)
|
1997-09-08 |
2002-02-12 |
Panacea Biotec Limited |
Pharmaceutical composition comprising cyclosporin
|
US6008191A
(en)
*
|
1997-09-08 |
1999-12-28 |
Panacea Biotec Limited |
Pharmaceutical compositions containing cyclosporin
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
DE69832984T2
(de)
|
1997-10-08 |
2006-09-21 |
Isotechnika, Inc., Edmonton |
DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
|
US6063762A
(en)
*
|
1997-12-05 |
2000-05-16 |
Chong Kun Dang Corp. |
Cyclosporin-containing microemulsion preconcentrate composition
|
WO1999029335A1
(en)
*
|
1997-12-05 |
1999-06-17 |
Chong Kun Dang Corp. |
Pharmaceutical composition containing cyclosporin
|
ID25908A
(id)
*
|
1998-03-06 |
2000-11-09 |
Novartis Ag |
Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
|
GB2380674B
(en)
*
|
1998-03-06 |
2003-05-28 |
Novartis Ag |
Emulsion preconcentrates containing cyclosporin or a macrolide
|
JP4350898B2
(ja)
|
1998-07-01 |
2009-10-21 |
デビオファーム・ソシエテ・アノニム |
活性の特徴が改善された新規のシクロスポリン
|
DE69828962D1
(de)
*
|
1998-07-30 |
2005-03-17 |
St Microelectronics Srl |
Verfahren zur Herstellung eines Aktuators für eine Festplattenvorrichtung, mit einem Lese-/Schreibkopf, einem Microaktuator und einer Aufhängung und die so erhaltene Aktuatorvorrichtung
|
DK0982035T3
(da)
*
|
1998-08-18 |
2004-06-28 |
Panacea Biotec Ltd |
Cyclosporinpræparater
|
SE9804192D0
(sv)
*
|
1998-12-03 |
1998-12-03 |
Scotia Lipidteknik Ab |
New formulation
|
GB2344520A
(en)
*
|
1998-12-08 |
2000-06-14 |
Phares Pharm Res Nv |
Pharmaceutical carriers comprising lipids and polymers
|
AU775523B2
(en)
|
1998-12-11 |
2004-08-05 |
Pharmasolutions, Inc. |
Self-emulsifying compositions for drugs poorly soluble in water
|
JP2002534370A
(ja)
|
1998-12-30 |
2002-10-15 |
デクセル リミテッド |
サイクロスポリンを送達するための分散可能な濃縮物
|
GB9903547D0
(en)
*
|
1999-02-16 |
1999-04-07 |
Novartis Ag |
Organic compounds
|
US6267985B1
(en)
*
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6294192B1
(en)
*
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6057289A
(en)
*
|
1999-04-30 |
2000-05-02 |
Pharmasolutions, Inc. |
Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
|
GB9912476D0
(en)
|
1999-05-28 |
1999-07-28 |
Novartis Ag |
Organic compounds
|
DE19925001A1
(de)
*
|
1999-05-31 |
2000-12-07 |
Pharma Concepts Gmbh & Co Kg |
Flüssiges Konzentrat
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
GB2355656B
(en)
*
|
1999-08-17 |
2004-04-07 |
Galena As |
Pharmaceutical compositions for oral and topical administration
|
JP2001122779A
(ja)
*
|
1999-10-26 |
2001-05-08 |
Toyo Capsule Kk |
経口投与用シクロスポリン含有ミクロエマルジョン濃縮液
|
AU1043201A
(en)
*
|
1999-11-02 |
2001-05-14 |
Cipla Limited |
Cyclosporin formulation
|
GB2362573A
(en)
*
|
2000-05-25 |
2001-11-28 |
Cipla Ltd |
Cyclosporin formulation
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US7919113B2
(en)
*
|
1999-12-30 |
2011-04-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dispersible concentrate lipospheres for delivery of active agents
|
JP2003522578A
(ja)
|
2000-02-18 |
2003-07-29 |
アーゴス インク |
不均質組織における空間的に平均された励起−発光マップの生成
|
GB0008785D0
(en)
|
2000-04-10 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
DE10029404B4
(de)
*
|
2000-06-15 |
2009-10-29 |
Jagotec Ag |
Arzneiformulierung enthaltend Ciclosporin und deren Verwendung
|
US6623765B1
(en)
*
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
EP1333851B1
(en)
|
2000-09-18 |
2007-08-22 |
RPG Life Sciences Limited |
Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
|
US6960563B2
(en)
*
|
2001-08-31 |
2005-11-01 |
Morton Grove Pharmaceuticals, Inc. |
Spontaneous emulsions containing cyclosporine
|
PL210795B1
(pl)
*
|
2001-10-19 |
2012-03-30 |
Isotechnika Inc |
Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247
|
NZ531946A
(en)
*
|
2001-10-19 |
2005-09-30 |
Isotechnika Inc |
Preconcentrate formulations comprising cyclosporin analogue microemulsions that reduce adverse effects while maintaining high bioavailability
|
US8568748B2
(en)
|
2001-12-14 |
2013-10-29 |
Jagotec Ag |
Pharmaceutical formulation comprising cyclosporin and use thereof
|
CA2471241A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Bernard Charles Sherman |
Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
|
JP2005531495A
(ja)
*
|
2001-12-21 |
2005-10-20 |
シャイア ラボラトリーズ,インコーポレイテッド |
高い物理的安定性を有する経口カプセル製剤
|
KR100441167B1
(ko)
*
|
2001-12-27 |
2004-07-21 |
씨제이 주식회사 |
마이크로에멀젼 예비 농축액 조성물
|
US20040005339A1
(en)
*
|
2002-06-28 |
2004-01-08 |
Shojaei Amir H. |
Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
|
KR20040047056A
(ko)
*
|
2002-11-29 |
2004-06-05 |
한미약품 주식회사 |
비페닐디메틸디카복실레이트의 경구용 마이크로에멀젼조성물
|
US6979672B2
(en)
|
2002-12-20 |
2005-12-27 |
Polichem, S.A. |
Cyclosporin-based pharmaceutical compositions
|
KR100525234B1
(ko)
*
|
2003-02-19 |
2005-10-28 |
한국유나이티드제약 주식회사 |
사이클로스포린 함유 연질캅셀제 및 그 제조방법
|
US20050196370A1
(en)
*
|
2003-03-18 |
2005-09-08 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
|
US7181219B2
(en)
|
2003-05-22 |
2007-02-20 |
Lucent Technologies Inc. |
Wireless handover using anchor termination
|
GB0320638D0
(en)
|
2003-09-03 |
2003-10-01 |
Novartis Ag |
Organic compounds
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
BRPI0416812A
(pt)
|
2003-11-21 |
2007-03-06 |
Combinatorx Inc |
métodos e reagentes para o tratamento de desordens inflamatórias
|
PE20050596A1
(es)
*
|
2003-12-19 |
2005-10-18 |
Novartis Ag |
Microemulsion que comprende un inhibidor renina
|
IL159729A0
(en)
*
|
2004-01-06 |
2004-06-20 |
Doron I Friedman |
Non-aqueous composition for oral delivery of insoluble bioactive agents
|
WO2005070399A1
(en)
*
|
2004-01-09 |
2005-08-04 |
Wyeth |
Microemulsions for pharmaceutical compositions
|
WO2005089716A1
(ja)
*
|
2004-03-24 |
2005-09-29 |
Takeda Pharmaceutical Company Limited |
高含量化製剤
|
WO2005089714A1
(ja)
*
|
2004-03-24 |
2005-09-29 |
Takeda Pharmaceutical Company Limited |
エマルション安定化製剤
|
WO2006039558A2
(en)
*
|
2004-10-09 |
2006-04-13 |
Formurex, Inc. |
Ocular agent delivery systems
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
US7151085B2
(en)
|
2004-11-15 |
2006-12-19 |
Allergan, Inc. |
Therapeutic methods using cyclosporine components
|
US20080233053A1
(en)
*
|
2005-02-07 |
2008-09-25 |
Pharmalight Inc. |
Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
|
GB0504950D0
(en)
|
2005-03-10 |
2005-04-20 |
Novartis Ag |
Organic compositions
|
CN101242842A
(zh)
|
2005-06-17 |
2008-08-13 |
诺瓦提斯公司 |
Sanglifehrin在hcv中的用途
|
US7202209B2
(en)
|
2005-07-13 |
2007-04-10 |
Allergan, Inc. |
Cyclosporin compositions
|
US20070015693A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US20070015691A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US7276476B2
(en)
*
|
2005-07-13 |
2007-10-02 |
Allergan, Inc. |
Cyclosporin compositions
|
US7297679B2
(en)
|
2005-07-13 |
2007-11-20 |
Allergan, Inc. |
Cyclosporin compositions
|
US7288520B2
(en)
|
2005-07-13 |
2007-10-30 |
Allergan, Inc. |
Cyclosporin compositions
|
US7501393B2
(en)
*
|
2005-07-27 |
2009-03-10 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
GT200600411A
(es)
*
|
2005-09-13 |
2007-05-21 |
Novartis Ag |
Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
US7745400B2
(en)
*
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
EP1956906A4
(en)
|
2005-11-09 |
2009-12-30 |
Combinatorx Inc |
METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF PATHOLOGIES
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
EP2001439A2
(en)
*
|
2006-03-07 |
2008-12-17 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
US20070221693A1
(en)
*
|
2006-03-24 |
2007-09-27 |
Moore Howard L |
Multi-purpose insulating and protective cover for containers
|
ITMI20060618A1
(it)
*
|
2006-03-31 |
2007-10-01 |
Enitecnologie Spa |
Procedimento per la preparazione di nanoemulsioni acqua ion olio e olio in acqua
|
EP2007789B1
(en)
|
2006-04-11 |
2015-05-20 |
Novartis AG |
Spirocyclic HCV/HIV inhibitors and their uses
|
MX2009006958A
(es)
*
|
2006-12-28 |
2009-07-09 |
Limerick Biopharma Inc |
Metodos y composiciones para tratamiento terapeutico.
|
MX2009007045A
(es)
|
2007-01-04 |
2009-10-07 |
Debiopharm Sa |
Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular congenita de ullrich.
|
CA2683409A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Sigmoid Pharma Limited |
A pharmaceutical composition of tacrolimus
|
ES2963291T3
(es)
|
2007-04-26 |
2024-03-26 |
Sublimity Therapeutics Ltd |
Fabricación de múltiples minicápsulas
|
US20110144010A1
(en)
*
|
2007-06-01 |
2011-06-16 |
Novo Nordisk A/S |
Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
|
CA2693338A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Limerick Biopharma, Inc. |
Phosphorylated pyrone analogs and methods
|
GB2451811A
(en)
|
2007-08-09 |
2009-02-18 |
Ems Sa |
Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
|
WO2009048929A1
(en)
*
|
2007-10-08 |
2009-04-16 |
Lux Biosciences, Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
|
BRPI0705564B8
(pt)
*
|
2007-10-10 |
2021-05-25 |
Embrapa Pesquisa Agropecuaria |
sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
|
TW200932240A
(en)
*
|
2007-10-25 |
2009-08-01 |
Astellas Pharma Inc |
Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
|
AU2009218456A1
(en)
*
|
2008-02-28 |
2009-09-03 |
Novartis Ag |
Combination comprising a cannabinoid receptor binding compound and an opioid
|
EP2257220B1
(en)
*
|
2008-03-13 |
2017-06-14 |
Liebel-Flarsheim Company LLC |
Multi-function, foot-activated controller for imaging system
|
DE102008015299A1
(de)
|
2008-03-18 |
2009-09-24 |
Pkh Gmbh Halle |
Kolloidales Trägersystem
|
PL2254906T3
(pl)
|
2008-03-18 |
2017-04-28 |
Novo Nordisk A/S |
Stabilizowane względem proteaz, acylowane analogi insuliny
|
WO2010080913A1
(en)
*
|
2009-01-08 |
2010-07-15 |
Allergan, Inc. |
Cyclosporine compositions for enhancing nail growth
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
EP2432455B1
(en)
|
2009-05-18 |
2014-11-12 |
Sigmoid Pharma Limited |
Composition comprising oil drops
|
CN102458370A
(zh)
*
|
2009-06-09 |
2012-05-16 |
卢克斯生物科技公司 |
用于眼科用途的表面药物递送系统
|
CA2770570A1
(en)
|
2009-08-12 |
2011-02-17 |
Sigmoid Pharma Limited |
Immunomodulatory compositions comprising a polymer matrix and an oil phase
|
EP2308468A1
(en)
*
|
2009-10-08 |
2011-04-13 |
Novaliq GmbH |
Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
|
US8324239B2
(en)
|
2010-04-21 |
2012-12-04 |
Novartis Ag |
Furopyridine compounds and uses thereof
|
US20120077778A1
(en)
*
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
US9011833B2
(en)
|
2010-10-08 |
2015-04-21 |
Novartis Ag |
Vitamin E formulations of sulfamide NS3 inhibitors
|
GB201020032D0
(en)
*
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
JO3337B1
(ar)
*
|
2010-12-13 |
2019-03-13 |
Debiopharm Sa |
تركيبات صيدلية تشمل أليسبوريفير
|
FR2971941B1
(fr)
|
2011-02-24 |
2013-08-02 |
Physica Pharma |
Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
|
KR101510764B1
(ko)
*
|
2011-10-10 |
2015-04-10 |
김용남 |
사이클로스포린 함유 안약 조성물 및 그 제조방법
|
MX2014012096A
(es)
|
2012-04-11 |
2014-11-21 |
Novo Nordisk As |
Formulaciones de insulina.
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
WO2014134427A1
(en)
*
|
2013-02-28 |
2014-09-04 |
Precision Dermatology, Inc. |
Controlling the bioavailability of active ingredients in topical formulations
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
PL3215127T3
(pl)
|
2014-11-07 |
2021-05-17 |
Sublimity Therapeutics Limited |
Kompozycje zawierające cyklosporynę
|
EP3187172A1
(en)
*
|
2016-01-04 |
2017-07-05 |
Spherium Biomed S.L. |
Cyclosporine a topical compositions
|
US20180147215A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
TWI700091B
(zh)
|
2016-12-16 |
2020-08-01 |
丹麥商諾佛 儂迪克股份有限公司 |
含胰島素醫藥組成物
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
WO2019002362A1
(en)
*
|
2017-06-28 |
2019-01-03 |
Spherium Biomed, S.L. |
TOPICAL COMPOSITIONS OF CYCLOSPORIN A
|
KR102146704B1
(ko)
*
|
2018-04-13 |
2020-08-21 |
가천대학교 산학협력단 |
사이클로스포린 A (CsA) 경피 및 피내 약물전달용 마이크로구조체
|
PT3886813T
(pt)
*
|
2018-11-26 |
2023-04-26 |
Hepion Pharmaceuticals Inc |
Formulações farmacêuticas de análogos de ciclosporina
|